Champions Oncology

(NASDAQ) CSBR

Current Price$6.09

Market Cap$83.60M

Since IPO (1992)-51%

5 Year-44%

1 Year-24%

1 Month+5%

Champions Oncology Financials at a Glance

Market Cap

$83.60M

Revenue (TTM)

$57.94M

Net Income (TTM)

$2.25M

EPS (TTM)

$-0.17

P/E Ratio

-36.13

Dividend

$0.00

Beta (Volatility)

0.40 (Low)

Dividend

$0.00

Beta (Volatility)

0.40 (Low)

Price

$6.09

Volume

Open

$6.15

Price

$6.09

Volume

Open

$6.15

Previous Close

$6.02

Daily Range

$6.09 - $6.15

52-Week Range

$5.50 - $9.63

Dividend

$0.00

Beta (Volatility)

0.40 (Low)

Price

$6.09

Volume

Open

$6.15

Previous Close

$6.02

Daily Range

$6.09 - $6.15

52-Week Range

$5.50 - $9.63

CSBR News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Champions Oncology

Industry

Life Sciences Tools and Services

Sector

Health Care

Employees

213

CEO

Robert Brainin

Website

www.championsoncology.com

Headquarters

Hackensack, NJ 07601, US

CSBR Financials

Key Financial Metrics (TTM)

Gross Margin

43%

Operating Margin

-4%

Net Income Margin

-4%

Return on Equity

-47%

Return on Capital

-29%

Return on Assets

-8%

Earnings Yield

-2.77%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$83.60M

Shares Outstanding

13.89M

Volume

Avg. Volume

7.85K

Financials (TTM)

Gross Profit

$26.91M

Operating Income

$4.85M

EBITDA

$6.29M

Operating Cash Flow

$7.39M

Capital Expenditure

$389.00K

Free Cash Flow

$7.00M

Cash & ST Invst.

$9.79M

Total Debt

$6.11M

Champions Oncology Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q3 2026YOY CHG

Revenue

$16.56M

-2.8%

Gross Profit

$7.38M

-26.3%

Gross Margin

44.59%

N/A

Market Cap

$83.60M

N/A

Market Cap/Employee

$398.09K

N/A

Employees

210

N/A

Net Income

$279.00K

-106.2%

EBITDA

$154.00K

-96.9%

Quarterly Fundamentals

Name

Q3 2026YOY CHG

Net Cash

$2.13M

+165.8%

Accounts Receivable

$12.07M

-23.5%

Inventory

$0.00

N/A

Long Term Debt

$3.39M

-32.2%

Short Term Debt

$1.61M

+12.1%

Return on Assets

-7.91%

N/A

Return on Invested Capital

-28.61%

N/A

Free Cash Flow

$1.38M

-407.1%

Operating Cash Flow

$1.34M

-373.3%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

IMAImageneBio Inc

IMAImageneBio Inc$5.72-1.89%

KLRSKalaris Therapeutics Inc

KLRSKalaris Therapeutics Inc$5.71-5.07%

MGXMetagenomi, Inc. Common Stock

MGXMetagenomi, Inc. Common Stock$1.45-2.03%

ATRAAtara Biotherapeutics, Inc.

ATRAAtara Biotherapeutics, Inc.$4.91-1.59%

IFRXInflaRx N.V.

IFRXInflaRx N.V.$1.85+15.16%

CNTBConnect Biopharma Holdings Limited

CNTBConnect Biopharma Holdings Limited$2.43-0.69%

ORMPOramed Pharmaceuticals Inc.

ORMPOramed Pharmaceuticals Inc.$4.09-0.49%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NOKNokia

NOKNokia$10.84+0.01%

POETPoet Technologies

POETPoet Technologies$7.92-0.00%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$12.07-0.02%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$60.23-0.04%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.14+0.07%

BBBYBeyond, Inc.

BBBYBeyond, Inc.$5.10-0.04%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$54.67+0.04%

Questions About CSBR

What is the current price of Champions Oncology?

Champions Oncology is trading at $6.09 per share.

What is the 52-week range for Champions Oncology?

Over the past 52 weeks, Champions Oncology has traded between $5.50 and $9.63.

How much debt does Champions Oncology have?

As of the most recent reporting period, Champions Oncology reported total debt of $5.00M.

How much cash does Champions Oncology have on hand?

Champions Oncology reported $7.13M in cash and cash equivalents in its most recent financial results.

What is Champions Oncology’s dividend yield?

Champions Oncology does not currently have a dividend yield.

Champions Oncology

Champions Oncology Financials at a Glance

CSBR News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Champions Oncology

CSBR Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Champions Oncology Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About CSBR

What is the current price of Champions Oncology?

What is the 52-week range for Champions Oncology?

How much debt does Champions Oncology have?

How much cash does Champions Oncology have on hand?

What is Champions Oncology’s dividend yield?

Premium Investing Services